TY - JOUR
T1 - Aggregation of Thy-1 glycoprotein induces thymocyte apoptosis through activation of CPP32-like proteases
AU - Fujita, Naoya
AU - Kodama, Nobuyuki
AU - Kato, Yukinari
AU - Lee, Sang Han
AU - Tsuruo, Takashi
N1 - Funding Information:
This study was supported in part by a special grant for Advanced Research on Cancer and a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture and Science, Japan.
PY - 1997/5/1
Y1 - 1997/5/1
N2 - Mouse thymocytes are known to undergo apoptosis by ligating some unique anti. Thy-1 monoclonal antibodies (mAbs), G7 and KT16. However, the precise mechanisms of Thy-1-mediated apoptosis are as yet unclear. We investigated Thy-1-mediated apoptosis using our previously generated anti-Thy-1 mAb, MCS- 34, which was similar to G7 because both antibodies recognized both Thy-1.1 and Thy-1.2 and bound Thy-1A epitope. Unlike G7, MCS-34 alone could not induce apoptosis in thymocytes; however, it could induce apoptosis when it was cross-linked with second antibodies. Thus, MCS-34 could not aggregate by itself, but G7 could. In the course of investigating the apoptosis-related molecules that were involved in the thymocyte apoptosis induced by cross- linking of MCS-34 or by G7 ligation, we found that CPP32-like proteases were activated during the apoptosis. Furthermore, the expression of bcl-2 and bcl-X(L) proteins was decreased in these apoptosis processes. Whereas the ligation of MCS-34 alone could not generate apoptosis signals that led to the activation of CPP32-like proteases and the decrease in bcl-2 and bcl- X(L) expression, the aggregation of Thy-1 glycoprotein might be crucial to signal thymocyte apoptosis. These results indicate that MCS-34 is a useful anti-Thy-1 mAb for analyzing the Thy-1-mediated signals since MCS-34 can control the level of apoptosis by using second antibodies.
AB - Mouse thymocytes are known to undergo apoptosis by ligating some unique anti. Thy-1 monoclonal antibodies (mAbs), G7 and KT16. However, the precise mechanisms of Thy-1-mediated apoptosis are as yet unclear. We investigated Thy-1-mediated apoptosis using our previously generated anti-Thy-1 mAb, MCS- 34, which was similar to G7 because both antibodies recognized both Thy-1.1 and Thy-1.2 and bound Thy-1A epitope. Unlike G7, MCS-34 alone could not induce apoptosis in thymocytes; however, it could induce apoptosis when it was cross-linked with second antibodies. Thus, MCS-34 could not aggregate by itself, but G7 could. In the course of investigating the apoptosis-related molecules that were involved in the thymocyte apoptosis induced by cross- linking of MCS-34 or by G7 ligation, we found that CPP32-like proteases were activated during the apoptosis. Furthermore, the expression of bcl-2 and bcl-X(L) proteins was decreased in these apoptosis processes. Whereas the ligation of MCS-34 alone could not generate apoptosis signals that led to the activation of CPP32-like proteases and the decrease in bcl-2 and bcl- X(L) expression, the aggregation of Thy-1 glycoprotein might be crucial to signal thymocyte apoptosis. These results indicate that MCS-34 is a useful anti-Thy-1 mAb for analyzing the Thy-1-mediated signals since MCS-34 can control the level of apoptosis by using second antibodies.
UR - http://www.scopus.com/inward/record.url?scp=0031149131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031149131&partnerID=8YFLogxK
U2 - 10.1006/excr.1997.3505
DO - 10.1006/excr.1997.3505
M3 - Article
C2 - 9168818
AN - SCOPUS:0031149131
SN - 0014-4827
VL - 232
SP - 400
EP - 406
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -